Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Thimerosal exposure & increasing trends of premature puberty in the vaccine safety datalink.

Geier DA, Young HA, Geier MR.

Indian J Med Res. 2010 Apr;131:500-7.

2.

An assessment of thimerosal use in childhood vaccines.

Ball LK, Ball R, Pratt RD.

Pediatrics. 2001 May;107(5):1147-54. Review.

PMID:
11331700
3.

Thimerosal as discrimination: vaccine disparity in the UN Minamata Convention on mercury.

Sykes LK, Geier DA, King PG, Kern JK, Haley BE, Chaigneau CG, Megson MN, Love JM, Reeves RE, Geier MR.

Indian J Med Ethics. 2014 Oct-Dec;11(4):206-18. Review.

PMID:
25101548
4.

Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

Dórea JG.

Neurochem Res. 2011 Jun;36(6):927-38. doi: 10.1007/s11064-011-0427-0. Review.

PMID:
21350943
5.

The evidence for the safety of thiomersal in newborn and infant vaccines.

Clements CJ.

Vaccine. 2004 May 7;22(15-16):1854-61. Review.

PMID:
15121295
6.
7.

[Safety of thimerosal containing vaccines. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society].

Muñoz M A, Abarca V K, Jiménez de la J J, Luchslnger F V, O'Ryan G M, Ripoll M E, Valenzuela B MT, Vergara F R.

Rev Chilena Infectol. 2007 Oct;24(5):372-6. Review. Spanish.

8.

[Mercury in vaccines].

Hessel L.

Bull Acad Natl Med. 2003;187(8):1501-10. Review. French.

PMID:
15146581
9.

The Vaccine Safety Datalink: a model for monitoring immunization safety.

Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E.

Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Review.

PMID:
21502240
10.

Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants.

Wigle DT, Arbuckle TE, Turner MC, Bérubé A, Yang Q, Liu S, Krewski D.

J Toxicol Environ Health B Crit Rev. 2008 May;11(5-6):373-517. doi: 10.1080/10937400801921320. Review.

PMID:
18470797
11.

Low-dose Thimerosal in pediatric vaccines: Adverse effects in perspective.

Dórea JG.

Environ Res. 2017 Jan;152:280-293. doi: 10.1016/j.envres.2016.10.028. Review.

PMID:
27816865
12.

Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.

Dórea JG.

Clin Chim Acta. 2010 Nov 11;411(21-22):1580-6. doi: 10.1016/j.cca.2010.07.008. Review.

PMID:
20638374
13.

Through the looking glass at early-life exposures and breast cancer risk.

Forman MR, Cantwell MM, Ronckers C, Zhang Y.

Cancer Invest. 2005;23(7):609-24. Review.

PMID:
16305989
14.

Vaccines and autism: evidence does not support a causal association.

DeStefano F.

Clin Pharmacol Ther. 2007 Dec;82(6):756-9. Review.

PMID:
17928818
15.

Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens.

Partsch CJ, Sippell WG.

Hum Reprod Update. 2001 May-Jun;7(3):292-302. Review.

PMID:
11392376
16.

How do environmental estrogen disruptors induce precocious puberty?

Massart F, Parrino R, Seppia P, Federico G, Saggese G.

Minerva Pediatr. 2006 Jun;58(3):247-54. Review.

PMID:
16832329

Supplemental Content

Support Center